Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2023 | Characteristics of NMOSD relapses

Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, discusses relapses in neuromyelitis optica spectrum disorders (NMOSD), compared to those in multiple sclerosis (MS). NMOSD relapses, though infrequent, are exceptionally severe, often resulting in blindness in one or both eyes after just one episode. Dr Oreja-Guevara emphasizes the importance of not only treating NMOSD relapses but also preventing them. She highlights three different treatments targeting C5, IL-6, and CD19, which offer promising relapse prevention. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.